The synthesis and SAR of new 4-(N-alkyl-N-phenyl)amino-6,7-dimethoxyquinazolines and 4-(N-alkyl-N-phenyl)aminopyrazolo[3,4-d]pyrimidines, inhibitors of CSF-1R tyrosine kinase activity
暂无分享,去创建一个
D. Cheney | A. Zilberstein | M. Myers | N. Setzer | A. Spada | P. Persons | C. Ly | M. Maguire | Allison L. Zulli | Susan E. Johnson | Carol F. Franks | K. Mitchell
[1] A. Zilberstein,et al. A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. , 1994, Journal of medicinal chemistry.
[2] W. Denny,et al. Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor. , 1995, Journal of medicinal chemistry.
[3] M. Parsons,et al. Reversible inhibitors of the gastric (H+/K+)-ATPase. 5. Substituted 2,4-diaminoquinazolines and thienopyrimidines. , 1995, Journal of medicinal chemistry.